|
시장보고서
상품코드
2052185
형질전환성장인자(TGF) 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)Transforming Growth Factor Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
형질전환성장인자(TGF) 시장은 감염, 자가면역질환, 암 연구 및 만성질환 분야에서 정확하고 신뢰할 수 있는 치료 및 진단 솔루션에 대한 수요가 증가함에 따라 견조한 성장세를 보이고 있습니다. 질병의 조기 발견에 대한 인식이 높아지고, 첨단 면역 측정법 및 분자생물학 기술의 급속한 보급으로 시장 확대가 더욱 가속화되고 있습니다. 시장 규모는 2026년 4억 844만 달러, 2033년에는 6억 4,310만 달러에 달할 것으로 예상되며, 예측 기간 동안 6.70%의 CAGR을 기록할 것으로 예상됩니다.
시장 인사이트:
혈청학, 면역진단 및 세포 신호 전달 연구 플랫폼의 지속적인 발전으로 업계는 큰 변화를 겪고 있습니다. 효소면역측정법(ELISA) 및 신속항체 검출 기술의 활용 확대로 진단 정확도가 향상됨과 동시에 검사 결과 보고까지의 시간이 크게 단축되었습니다. 의료진과 연구기관은 질병 모니터링, 임상 연구, 치료법 개발에 있어 항체 기반 및 성장인자 기반 검사법에 대한 의존도가 높아지고 있습니다. 또한, 검사 시설 인프라 및 생명과학 연구에 대한 투자 증가로 인해 전 세계 검사 및 분석 역량이 강화되고 있습니다.
성장 요인:
주요 성장 요인으로는 만성질환 및 감염성 질환 발생률 증가, 고령 인구 증가, 첨단 현장 진단 및 연구 솔루션에 대한 수요 증가 등을 꼽을 수 있습니다. 의료 인프라 강화와 질병 감시 시스템 개선을 위한 정부의 노력도 시장 확대에 힘을 보태고 있습니다. 또한, 자동화, 하이스루풋 스크리닝, 바이오인포매틱스 통합의 발전은 실험실의 효율성 향상, 운영 비용 절감, 연구 성과 향상에 기여하고 있습니다.
비즈니스 기회:
이 시장은 혁신적인 어세이 키트, 재조합 단백질, 첨단 실험실 플랫폼에 주력하는 생명공학 기업, 진단 기기 제조업체, 연구 솔루션 제공업체에게 큰 성장 기회를 제공하고 있습니다. 신흥국에서는 의료 시스템 개선, 연구 자금 확대, 예방의학에 대한 인식이 높아짐에 따라 강력한 성장 잠재력이 기대되고 있습니다. 제약사, 생명공학 기업 및 학술 연구기관 간의 전략적 제휴는 혁신을 촉진하고, 제품 개발을 가속화하며, 신기술의 상용화를 지원할 것으로 기대됩니다.
지역 분석:
북미는 탄탄한 의료 인프라, 높은 연구 역량, 그리고 주요 생명공학 및 제약 기업의 존재에 힘입어 시장을 독점하고 있습니다. 유럽은 활발한 학술 연구 활동과 지원적인 규제 환경에 힘입어 북미를 근소한 차이로 추격하고 있습니다. 아시아태평양은 의료 투자 증가, 연구 생태계 확대, 방대한 환자 기반으로 인해 가장 빠른 성장이 예상되는 지역입니다. 라틴아메리카, 중동 및 아프리카에서도 의료 및 연구 인프라가 점차 개선되고 있으며, 이는 전체 시장 확대에 기여하고 있습니다.
주요 기업:
- Genentech
- Novartis
- Pfizer
- Roche
- Merck & Co.
- Johnson & Johnson
- Amgen
- Eli Lilly and Company
- Sanofi
- AstraZeneca
- AbbVie
- Bristol Myers Squibb
세분화:
제품 유형별
- 골형성 단백질(BMP)
- TGF-β 단백질
용도별
- 종양학 연구
- 혈액학 연구
- 상처 치유 연구
- 피부과학 연구
- 심혈관질환 및 당뇨병
- 세포 치료 및 Ex vivo 제조
- 기타
지역별
- 북미
- 라틴아메리카
- 북미
- 동아시아
- 남아시아·오세아니아
목차
제1장 주요 요약
제2장 시장 개요
제3장 세계의 형질전환성장인자 시장 전망, 2020-2033년
제4장 북미의 형질전환성장인자 시장 전망, 2020-2033년
제5장 유럽의 형질전환성장인자 시장 전망, 2020-2033년
제6장 아시아태평양의 형질전환성장인자 시장 전망, 2020-2033년
제7장 라틴아메리카의 형질전환성장인자 시장 전망, 2020-2033년
제8장 중동 및 아프리카의 형질전환성장인자 시장 전망, 2020-2033년
제9장 경쟁 구도
제10장 부록
KSM 26.06.11The Transforming Growth Factor Market is witnessing robust growth, driven by increasing demand for precise and reliable therapeutic and diagnostic solutions across infectious diseases, autoimmune disorders, cancer research, and chronic conditions. Growing awareness of early disease detection and the rapid adoption of advanced immunoassay and molecular biology technologies are further accelerating market expansion. The market is projected to reach US$ 408.44 Mn in 2026 and US$ 643.1 Mn by 2033, registering a CAGR of 6.70% during the forecast period.
Market Insights:
The industry is undergoing significant transformation due to continuous advancements in serology, immunodiagnostics, and cellular signaling research platforms. The increasing utilization of enzyme-linked immunosorbent assays and rapid antibody detection technologies has improved diagnostic precision while significantly reducing turnaround time. Healthcare providers and research institutions are increasingly relying on antibody-based and growth factor-based assays for disease monitoring, clinical research, and therapeutic development. Moreover, rising investments in laboratory infrastructure and life sciences research are enhancing global testing and analytical capabilities.
Drivers:
Major growth drivers include the rising incidence of chronic and infectious diseases, increasing geriatric population, and expanding demand for advanced point-of-care diagnostic and research solutions. Government initiatives aimed at strengthening healthcare infrastructure and improving disease surveillance systems are further supporting market expansion. In addition, advancements in automation, high-throughput screening, and bioinformatics integration are helping laboratories improve efficiency, reduce operational costs, and enhance research output.
Business Opportunity:
The market presents substantial opportunities for biotechnology companies, diagnostic manufacturers, and research solution providers focused on innovative assay kits, recombinant proteins, and advanced laboratory platforms. Emerging economies offer strong growth potential due to improving healthcare systems, expanding research funding, and rising awareness of preventive healthcare. Strategic partnerships between pharmaceutical companies, biotechnology firms, and academic research institutes are expected to drive innovation, accelerate product development, and support commercialization of new technologies.
Region Analysis:
North America dominates the market, supported by strong healthcare infrastructure, advanced research capabilities, and the presence of leading biotechnology and pharmaceutical companies. Europe follows closely, driven by strong academic research activity and supportive regulatory environments. The Asia Pacific region is expected to witness the fastest growth due to increasing healthcare investments, expanding research ecosystems, and a large patient population base. Latin America and the Middle East and Africa are also experiencing gradual improvements in healthcare and research infrastructure, contributing to overall market expansion.
Key Players:
- Genentech
- Novartis
- Pfizer
- Roche
- Merck & Co.
- Johnson & Johnson
- Amgen
- Eli Lilly and Company
- Sanofi
- AstraZeneca
- AbbVie
- Bristol Myers Squibb
Segmentation:
By Product type
- Bone Morphogenetic Proteins (BMPs)
- TGF-beta Protein
By Application
- Oncology Research
- Hematology Research
- Wound Healing Research
- Dermatology Research
- Cardiovascular Disease & Diabetes
- Cell therapy and Ex vivo manufacturing
- Others
By Region
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
Table of Contents
1. Executive Summary
- 1.1. Global Transforming Growth Factor Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Transforming Growth Factor Market Outlook, 2020 - 2033
- 3.1. Global Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
- 3.1.1. Bone Morphogenetic Proteins (BMPs)
- 3.1.2. TGF-beta Protein
- 3.2. Global Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 3.2.1. Oncology Research
- 3.2.2. Hematology Research
- 3.2.3. Wound Healing Research
- 3.2.4. Dermatology Research
- 3.2.5. Cardiovascular Disease & Diabetes
- 3.2.6. Cell therapy and Ex vivo manufacturing
- 3.2.7. Others
- 3.3. Global Transforming Growth Factor Market Outlook, by Region, Value (US$ Mn), 2020-2033
- 3.3.1. North America
- 3.3.2. Europe
- 3.3.3. Asia Pacific
- 3.3.4. Latin America
- 3.3.5. Middle East & Africa
4. North America Transforming Growth Factor Market Outlook, 2020 - 2033
- 4.1. North America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
- 4.1.1. Bone Morphogenetic Proteins (BMPs)
- 4.1.2. TGF-beta Protein
- 4.2. North America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 4.2.1. Oncology Research
- 4.2.2. Hematology Research
- 4.2.3. Wound Healing Research
- 4.2.4. Dermatology Research
- 4.2.5. Cardiovascular Disease & Diabetes
- 4.2.6. Cell therapy and Ex vivo manufacturing
- 4.2.7. Others
- 4.3. North America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 4.3.1. U.S. Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 4.3.2. U.S. Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 4.3.3. Canada Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 4.3.4. Canada Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 4.4. BPS Analysis/Market Attractiveness Analysis
5. Europe Transforming Growth Factor Market Outlook, 2020 - 2033
- 5.1. Europe Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
- 5.1.1. Bone Morphogenetic Proteins (BMPs)
- 5.1.2. TGF-beta Protein
- 5.2. Europe Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 5.2.1. Oncology Research
- 5.2.2. Hematology Research
- 5.2.3. Wound Healing Research
- 5.2.4. Dermatology Research
- 5.2.5. Cardiovascular Disease & Diabetes
- 5.2.6. Cell therapy and Ex vivo manufacturing
- 5.2.7. Others
- 5.3. Europe Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 5.3.1. Germany Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 5.3.2. Germany Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 5.3.3. Italy Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 5.3.4. Italy Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 5.3.5. France Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 5.3.6. France Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 5.3.7. U.K. Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 5.3.8. U.K. Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 5.3.9. Spain Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 5.3.10. Spain Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 5.3.11. Russia Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 5.3.12. Russia Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 5.3.13. Rest of Europe Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 5.3.14. Rest of Europe Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 5.4. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Transforming Growth Factor Market Outlook, 2020 - 2033
- 6.1. Asia Pacific Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
- 6.1.1. Bone Morphogenetic Proteins (BMPs)
- 6.1.2. TGF-beta Protein
- 6.2. Asia Pacific Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 6.2.1. Oncology Research
- 6.2.2. Hematology Research
- 6.2.3. Wound Healing Research
- 6.2.4. Dermatology Research
- 6.2.5. Cardiovascular Disease & Diabetes
- 6.2.6. Cell therapy and Ex vivo manufacturing
- 6.2.7. Others
- 6.3. Asia Pacific Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 6.3.1. China Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 6.3.2. China Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 6.3.3. Japan Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 6.3.4. Japan Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 6.3.5. South Korea Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 6.3.6. South Korea Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 6.3.7. India Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 6.3.8. India Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 6.3.9. Southeast Asia Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 6.3.10. Southeast Asia Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 6.3.11. Rest of SAO Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 6.3.12. Rest of SAO Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 6.4. BPS Analysis/Market Attractiveness Analysis
7. Latin America Transforming Growth Factor Market Outlook, 2020 - 2033
- 7.1. Latin America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
- 7.1.1. Bone Morphogenetic Proteins (BMPs)
- 7.1.2. TGF-beta Protein
- 7.2. Latin America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 7.2.1. Oncology Research
- 7.2.2. Hematology Research
- 7.2.3. Wound Healing Research
- 7.2.4. Dermatology Research
- 7.2.5. Cardiovascular Disease & Diabetes
- 7.2.6. Cell therapy and Ex vivo manufacturing
- 7.2.7. Others
- 7.3. Latin America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 7.3.1. Brazil Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 7.3.2. Brazil Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 7.3.3. Mexico Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 7.3.4. Mexico Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 7.3.5. Argentina Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 7.3.6. Argentina Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 7.3.7. Rest of LATAM Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 7.3.8. Rest of LATAM Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 7.4. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Transforming Growth Factor Market Outlook, 2020 - 2033
- 8.1. Middle East & Africa Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn), 2020-2033
- 8.1.1. Bone Morphogenetic Proteins (BMPs)
- 8.1.2. TGF-beta Protein
- 8.2. Middle East & Africa Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn), 2020-2033
- 8.2.1. Oncology Research
- 8.2.2. Hematology Research
- 8.2.3. Wound Healing Research
- 8.2.4. Dermatology Research
- 8.2.5. Cardiovascular Disease & Diabetes
- 8.2.6. Cell therapy and Ex vivo manufacturing
- 8.2.7. Others
- 8.3. Middle East & Africa Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn), 2020-2033
- 8.3.1. GCC Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 8.3.2. GCC Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 8.3.3. South Africa Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 8.3.4. South Africa Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 8.3.5. Egypt Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 8.3.6. Egypt Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 8.3.7. Nigeria Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 8.3.8. Nigeria Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 8.3.9. Rest of Middle East Transforming Growth Factor Market Outlook, by Product, 2020-2033
- 8.3.10. Rest of Middle East Transforming Growth Factor Market Outlook, by Application, 2020-2033
- 8.4. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Genentech
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Novartis
- 9.4.3. Pfizer
- 9.4.4. Roche
- 9.4.5. Merck & Co.
- 9.4.6. Johnson & Johnson
- 9.4.7. Amgen
- 9.4.8. Eli Lilly and Company
- 9.4.9. Sanofi
- 9.4.10. AstraZeneca
- 9.4.11. AbbVie
- 9.4.12. Bristol Myers Squibb
- 9.4.1. Genentech
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
